The Food and Drug Administration (FDA) performed an inspection at Aykut Bayrak A Professional Corporation, M.D. in Los Angeles on April 15, reviewing practices related to human cellular, tissue and gene therapies, according to data on the FDA’s website.
The inspection’s final report noted there was no need for Aykut Bayrak A Professional Corporation, M.D. to address any issues concerning its management operations.
The FDA regularly evaluates facilities nationwide to ensure their operations and products comply with FDA-enforced laws and standards designed to protect public health. The outcomes of these inspections are made available to the public.
The agency’s website states that the FDA is tasked with overseeing the safety and quality of human and animal drug production, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
